Navigation Links
Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
Date:2/4/2008

MADISON, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that it will present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference on Thursday, February 7, 2008 at 10:20 a.m. Eastern Time. Presenting for Wyeth will be Geno Germano, President, U.S. Pharmaceuticals & Women's Health Care, Wyeth Pharmaceuticals.

Wyeth's presentation will be webcast live for investors at http://www.wyeth.com and available for replay following the conference.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events that involve risks and uncertainties including, without limitation, risks associated with the inherent uncertainty of the timing and success of pharmaceutical research, product development, manufacturing, commercialization, economic conditions including interest and currency exchange rate fluctuations, changes in generally accepted accounting principles, the impact of competitive or generic products, trade buying patterns, wars or terrorist acts, product liability and other types of lawsuits, the impact of legislation and regulatory compliance and obtaining reimbursement, favorable drug pricing, access an
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
2. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
3. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
6. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
7. Wyeth Declares Preferred Stock Dividend
8. Wyeth Announces Election of New Principal Corporate Officer
9. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
10. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
11. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosystem... re-filed the Form 52-109F1 Certification of Annua...fficer and James Long, the Chief Financial Officer...2009 in connection with the annual audited financi...8. ,, The Company initially filed the annual fi...
(Date:11/6/2009)..., Calif., Nov. 6 ,, ...ansfer of Qutenza(TM) E.U. Marketing Authorization... progress in commercial readiness activities Expa...irector, Marketing; and Director, Commercial Opera...irector and Audit Committee chairman , Upco...
(Date:11/5/2009)...TION -- Gone hybrid . . . , Fuel economy ratin... posted at the www.fueleconomy.gov web site, whi...ntains for the U.S. Department of Energy and the U...op 10 vehicles on the best fuel economy list are h...ity; 48 highway). "This list proves that hybrids h...
(Date:11/5/2009)...RDOVA, Calif., Nov. 5 Th...lier of innovative products for processing and sto...the first quarter of fiscal 2010. ,, For the qu...ed revenues of $5.2 million, a 15 percent increase...r a year ago. The Company said the key contributor...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...vestor Syndicate, VIENNA, Austria, March 28 f-st...el antibodies and antibody fragments,based on its ...y that it,has acquired future royalty obligations ... payment., Modular Antibody Technology was origin...tar,s founders, in collaboration with NCP, a U.S.,...
...March 28 Mentice AB, a leading,supplier of virtua...ield of,medicine has recently appointed Lars Lonn ..., an Interventional Radiologist, is also a leading...ar Surgery and a faculty,member of Rigshospital He...Lonn recently completed a study with Max Berry, MD...
...Scientists have developed a new form of stretchabl...complex shapes such as spheres, body parts and air...mpressing, folding and other types of extreme mech...ical performance. , The notion that silicon cannot...sically brittle and rigid has been tossed out the ...
Other Biology Technology:Antibody Engineering Company F-Star Buys Back Royalty Obligations 2Foldable and stretchable, silicon circuits conform to many shapes 2Foldable and stretchable, silicon circuits conform to many shapes 3
(Date:11/8/2009)...LTH EDUCATION DESIGNED FOR ADULTS WITH INTELLECTUA... , An Indiana University study involving adults...lts increased their personal health knowledge afte...Adults with ID, an internationally accepted term f...of obesity, physical inactivity and preventable ch...
(Date:11/6/2009)...LPHIA (November 06, 2009) The Monell Center and t...of the Beijing International Meeting on Taste and ...on with the CAS, the meeting will be the first int...n China. , Alan Leshner, Chief Executive Officer...nce and Executive Publisher of Science magazine, w...
(Date:11/4/2009)...S: (top news in natural science) , United Stat...ses less water today than it did 35 years ago, des... water use are partly attributable to alternative ... irrigation systems. According to the latest USGS ... the United States goes to cooling thermoelectric ...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Running a Marathon The realbuzz com Beginners Guide 58910 1Running a Marathon The realbuzz com Beginners Guide 58910 2Running a Marathon The realbuzz com Beginners Guide 58910 3News briefs from the October issue of Chest 58908 1News briefs from the October issue of Chest 58908 2Cytopia Merger with Toronto based YM BioSciences Inc 14360 1Cytopia Merger with Toronto based YM BioSciences Inc 14360 2Cytopia Merger with Toronto based YM BioSciences Inc 14360 3Cytopia Merger with Toronto based YM BioSciences Inc 14360 4Cytopia Merger with Toronto based YM BioSciences Inc 14360 5Cytopia Merger with Toronto based YM BioSciences Inc 14360 6Cytopia Merger with Toronto based YM BioSciences Inc 14360 7
...ngoing quest, a group of Scripps Research Institut...rsity of California, San Diego, (UCSD) have borrow...aritiesan unmitigated success. The group has devis...curacy, predicts how bacterial proteins fold and i..., described in this week,s Early Edition of the P...
...ncer is typically without symptoms until it has sp...ficult to treat. Newer chemotherapies show great p... stages, but they can also be highly toxic. , In...s Cancer Center researchers have identified ways t...in so doing, help make chemotherapy for kidney can...
... acts as a computer to both store information and ...devices perform these roles; while a hard disk sto... does the processing. But the brain is thought to ...urons leading researchers to ask if distinct mole... functions. , In a discovery that may one day le...
Other Biology News:New technique is quantum leap forward in understanding proteins 2New technique is quantum leap forward in understanding proteins 3New technique is quantum leap forward in understanding proteins 4UC Davis discovery offers hope for treating kidney cancer 2SUNY Downstate researchers find that memory storage molecule preserves complex memories 2
BMP-2 ELISA Kit from R&D Systems
5x MONO-RABBIT POLY C'GATE DILUENT from AbD Serotec
Argarase from BioVision
SAMPLE DILUENTS BUFFER TRIAL PACK from AbD Serotec
Biology Products: